1. Home
  2. RDY vs NDSN Comparison

RDY vs NDSN Comparison

Compare RDY & NDSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • NDSN
  • Stock Information
  • Founded
  • RDY 1984
  • NDSN 1935
  • Country
  • RDY India
  • NDSN United States
  • Employees
  • RDY N/A
  • NDSN N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • NDSN Industrial Machinery/Components
  • Sector
  • RDY Health Care
  • NDSN Industrials
  • Exchange
  • RDY Nasdaq
  • NDSN Nasdaq
  • Market Cap
  • RDY 11.6B
  • NDSN 12.9B
  • IPO Year
  • RDY N/A
  • NDSN N/A
  • Fundamental
  • Price
  • RDY $13.93
  • NDSN $230.47
  • Analyst Decision
  • RDY Strong Buy
  • NDSN Strong Buy
  • Analyst Count
  • RDY 1
  • NDSN 6
  • Target Price
  • RDY $16.90
  • NDSN $265.33
  • AVG Volume (30 Days)
  • RDY 1.2M
  • NDSN 282.6K
  • Earning Date
  • RDY 10-24-2025
  • NDSN 12-10-2025
  • Dividend Yield
  • RDY 0.51%
  • NDSN 1.42%
  • EPS Growth
  • RDY 9.95
  • NDSN N/A
  • EPS
  • RDY 0.79
  • NDSN 7.95
  • Revenue
  • RDY $3,851,623,984.00
  • NDSN $2,784,349,000.00
  • Revenue This Year
  • RDY $6.29
  • NDSN $6.21
  • Revenue Next Year
  • RDY $2.61
  • NDSN $4.45
  • P/E Ratio
  • RDY $17.71
  • NDSN $28.96
  • Revenue Growth
  • RDY 14.10
  • NDSN 4.49
  • 52 Week Low
  • RDY $12.26
  • NDSN $165.03
  • 52 Week High
  • RDY $16.17
  • NDSN $266.86
  • Technical
  • Relative Strength Index (RSI)
  • RDY 50.51
  • NDSN 45.76
  • Support Level
  • RDY $13.79
  • NDSN $228.79
  • Resistance Level
  • RDY $14.02
  • NDSN $239.45
  • Average True Range (ATR)
  • RDY 0.22
  • NDSN 4.54
  • MACD
  • RDY 0.04
  • NDSN -0.39
  • Stochastic Oscillator
  • RDY 52.81
  • NDSN 23.53

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About NDSN Nordson Corporation

Nordson manufactures equipment (including pumps, valves, dispensers, applicators, filters, and pelletizers) used for dispensing adhesives, coatings, sealants, and other materials. The firm serves a diverse range of end markets including packaging, medical, electronics, and industrial. Nordson's business is organized into three segments: industrial precision solutions, medical and fluid solutions, and advanced technology solutions. The company generated approximately $2.7 billion in revenue in its fiscal 2024.

Share on Social Networks: